Adipose-derived stem cells ameliorate atopic dermatitis by suppressing the IL-17 expression of Th17 cells in an ovalbumin-induced mouse model

BACKGROUND: Mesenchymal stem cells (MSCs) have therapeutic potential for atopic dermatitis (AD) owing to their immunoregulatory effects. However, the underlying mechanisms associated with the therapeutic efficacy of MSCs on AD are diverse and related to both cell type and delivery method. OBJECTIVES...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Jingyan, Li, Yibao, Lu, Feng, Feng, Jingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900338/
https://www.ncbi.nlm.nih.gov/pubmed/35255962
http://dx.doi.org/10.1186/s13287-022-02774-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900338/
https://www.ncbi.nlm.nih.gov/pubmed/35255962
http://dx.doi.org/10.1186/s13287-022-02774-7

Ejemplares similares